login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
BIONTECH SE-ADR (BNTX) Stock News
USA
-
Nasdaq
- NASDAQ:BNTX -
US09075V1026
-
ADR
102.7
USD
+2.99 (+3%)
Last: 11/26/2025, 8:18:11 PM
101.84
USD
-0.86 (-0.84%)
Pre-Market:
11/28/2025, 4:50:23 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
BNTX Latest News, Press Relases and Analysis
All
Press Releases
16 hours ago - By: The Motley Fool
BioNTech (BNTX) Q3 2025 Earnings Call Transcript
2 days ago - By: BioNTech SE
BioNTech informiert über Fortschritte im Rahmen des Umtauschangebots für CureVac-Aktien und weist auf Ablauf des Angebots am 3. Dezember 2025 um 15 Uhr MEZ hin
2 days ago - By: BioNTech SE
BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration
2 days ago - By: BioNTech SE
BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration
2 months ago - By: Benzinga
Beyond The Numbers: 7 Analysts Discuss BioNTech Stock
11 days ago - By: Zacks Investment Research
- Mentions:
BMY
JNJ
CYTK
BMY Stock Down on Discontinuation of ACS Clinical Study With JNJ
15 days ago - By: Benzinga
- Mentions:
BMY
NVO
PFE
MTSR
Pfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run
15 days ago - By: Stocktwits
- Mentions:
PFE
F
BioNTech Says Collaboration With Pfizer Going Strong After Report Indicated US Pharma Giant Considering Stake Sale In The German Company
15 days ago - By: Bloomberg
- Mentions:
PFE
Pfizer Looks to Sell Stake in Pandemic Vaccine Partner BioNTech
25 days ago - By: BioNTech SE
BioNTech veröffentlicht Ergebnisse für das dritte Quartal 2025 sowie Informationen zur Geschäftsentwicklung
25 days ago - By: BioNTech SE
BioNTech Announces Third Quarter 2025 Financial Results and Corporate Update
25 days ago - By: BioNTech SE
BioNTech Announces Third Quarter 2025 Financial Results and Corporate Update
a month ago - By: Zacks Investment Research
- Mentions:
BMY
PFE
ALKS
BMY Beats on Q3 Earnings and Sales, Raises 2025 Sales View
a month ago - By: BioNTech SE
BioNTech veranstaltet am 11. November 2025 „Innovation Series Day“ zu Forschung & Entwicklung
a month ago - By: BioNTech SE
BioNTech to Host Innovation Series R&D Day on November 11, 2025
a month ago - By: BioNTech SE
BioNTech to Host Innovation Series R&D Day on November 11, 2025
a month ago - By: Zacks Investment Research
- Mentions:
BMY
PFE
Should You Buy, Hold, or Sell BMY Stock Ahead of Q3 Earnings?
a month ago - By: BioNTech SE
BioNTech veröffentlicht am 3. November 2025 Ergebnisse für das dritte Quartal 2025 und informiert über operativen Fortschritt
a month ago - By: BioNTech SE
BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025
a month ago - By: BioNTech SE
BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025
a month ago - By: The Motley Fool
- Mentions:
PFE
O
MTSR
2 Unstoppable Dividend Stocks Yielding More Than 4% That Income-Seeking Investors Will Want to Buy in November and Hold Forever
a month ago - By: BioNTech SE
BioNTech beginnt öffentliches Umtauschangebot für alle ausstehenden Aktien von CureVac N.V.
a month ago - By: BioNTech SE
BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V.
a month ago - By: BioNTech SE
BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V.
a month ago - By: Zacks Investment Research
- Mentions:
PFE
BMY
Pfizer's Q3 Non-Oncology Performance: Here's What to Expect
2 months ago - By: Zacks Investment Research
- Mentions:
PFE
MRK
MRNA
Could MRNA's Upcoming Product Launches Reduce COVID Sales Dependency?
2 months ago - By: BioNTech SE
BioNTech veranstaltet am 1. Oktober 2025 zweiten „AI Day“ als eine Ausgabe der „Innovation Series“
2 months ago - By: BioNTech SE
BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025
2 months ago - By: BioNTech SE
BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025
2 months ago - By: Investor's Business Daily
- Mentions:
PFE
MRNA
NVAX
CDC Ends Universal Covid Vaccine Recommendation; Moderna Skids
2 months ago - By: Investor's Business Daily
- Mentions:
PFE
MRNA
NVAX
The Battle Over Covid Vaccines Hits A Fever Pitch As RFK-Picked Panel Makes Its Debut
Please enable JavaScript to continue using this application.